<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<title>IV International conference of IACMAC ''Antimicrobial Chemotherapy''</title>
<meta name="description" content="IV International conference of IACMAC ''Antimicrobial Chemotherapy''">
<meta name="keywords" content="">
<script language="JavaScript1.2"> <!--//
function btn(ind,picture) {document.images[ind].src=picture;}
//--> </script>

<script language="JavaScript"> <!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/en/inc/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../inc/ie.css"></noscript>

<style type="text/css">
P {margin-top: 10px; margin-left: 2px; margin-right: 2px; text-align: justify;}
UL {margin-top: 5px; margin-left: 15px;}
OL {margin-top: 5px; margin-left: 22px;}
LI {margin-top: 6px; margin-left: 5px;}
UL.title {font-family: Arial,Verdana,Helvetica,Sans-Serif; font-size: 11pt; font-weight: bold;  letter-spacing: 1px; }
LI.title {font-family: Arial,Verdana,Helvetica,Sans-Serif; font-size: 11pt; font-weight: bold;  letter-spacing: 1px; }
H4 {font-size: 11pt; margin-left: 2px; margin-bottom: 5px;}
H5 {font-family: Arial,Verdana,Helvetica,Sans-Serif; font-size: 12pt; font-weight: bold; color: #663333; letter-spacing: 1px; text-align: center; margin-top: 5px; margin-bottom: 3px;}
H6 {font-family: Arial,Verdana,Helvetica,Sans-Serif; font-size: 11pt; font-weight: bold; color: #663333; letter-spacing: 1px; text-align: center; margin-top: 5px; margin-bottom: 5px;}
.par1 {font-family: Verdana,Arial,Helvetica,Sans-Serif; font-size: 16pt; font-weight: bold; letter-spacing: 1px; margin-top: -30px; margin-left: -8px; text-align: center; }
.par2 {font-family: Verdana,Arial,Helvetica,Sans-Serif; font-size: 16pt; font-weight: bold; letter-spacing: 1px; margin-top: 1px; margin-left: 1px; text-align: center;}
TH.f {background-color: #E4D0B4; text-align: center;}
</style>
</head>
<body class="main">

<center>
<!--navigation-->
<map name="TopBtnEn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Previous page" title="Previous page">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Next page" title="Next page">
<area shape="circle" coords="77,15,15" href="../../index-1.htm" alt="Main page" title="Main page">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="E-Mail" title="E-Mail">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../rus/images/buttons/topline.gif);" width="98%" height="32"><img src="../../../rus/images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../rus/images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Navigation" usemap="#TopBtnEn"></font></td>
</tr>
</table>
<!--/navigation-->

<div align="center"><font size="1"><img src="../../../rus/images/logo/iacmac.gif" width="54" height="75" border="0" alt="IACMAC"></font></div>

<h5>Ministry of Health of Russian Federation</h5>
<h5>Russian Academy of Medical Sciences</h5>
<h5><a class="nc" target="_blank" href="../../../iacmac/en/index.htm">Interregional Association for Clinical Microbiology <br>and Antimicrobial Chemotherapy </a> 
<br>(IACMAC)</h5>
<br><br>

<div class="par2"><font color="#D9C5AF">PROGRAMME</font></div><div class="par1"><font color="#663333">PROGRAMME</font></div><br>

<div class="par2"><font color="#D9C5AF">OF THE IV INTERNATIONAL</font></div><div class="par1"><font color="#663333">OF THE IV INTERNATIONAL</font></div><br>

<div class="par2"><font color="#D9C5AF">IACMAC CONFERENCE</font></div><div class="par1"><font color="#663333">IACMAC CONFERENCE</font></div><br>

<div class="par2"><font color="#D9C5AF">&quot;ANTIMICROBIAL THERAPY&quot;</font></div><div class="par1"><font color="#A52A2A">&quot;ANTIMICROBIAL THERAPY&quot;</font></div>

<br><br>
<h6>20-21 June 2001<br>Moscow, Russian Federation<br>
Conference Venue: Russian Academy of State Service (RASS)<br>
of the President of the Russian Federation</h6>

<br><br><h3>WITH PARTICIPATION OF</h3>

<h5><a class="nc" target="_blank" href="http://www.asmusa.org/">American Society for Microbiology (ASM) </a></h5>

<h5>European Commission (EC)</h5>

<h5><a class="nc" target="_blank" href="http://www.escmid.org/frameless.html">European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</a> </h5>

<h5><a class="nc" target="_blank" href="../../../index-87.htm">Federation of European Societies for Chemotherapy and for Infection (FESCI)</a></h5>

<h5><a class="nc" target="_blank" href="http://www.isid.org/">International Society for Infectious Diseases (ISID)</a></h5>

<h5>Paul-Erlich Gesellschaft (PEG)</h5>

<br><hr size="1"><br><br>
<h3>Tuesday, 19 June 2001</h3>

<table border="0" cellpadding="0" cellspacing="5" width="100%"><tr><td bgcolor="#CC9988">
<table border="0" cellpadding="5" cellspacing="1" width="100%">
<tr><th colspan="3"><h5>Round-table discussion</h5></th></tr>
<tr><td colspan="3" bgcolor="#F0E8DA"><h5><font color="#990000">RESPIRATORY FLUOROQUINOLONES</font></h5>
<div align="center"><i>Supported by &quot;Aventis Pharma&quot;</i></div></td></tr>
<tr>
  <td class="cc" nowrap="" width="15%">19.00 - 19.20 <br><img src="../../../rus/images/inv.gif" width="100" height="1" alt="" border="0"></td>
  <td class="cl">Evolution of fluoroquinolones as drugs for treatment of respiratory tract infections</td>
  <td class="cl" width="25%">A.&nbsp;Bryskier (France)</td>
</tr>
<tr>
  <td class="cc">19.20 - 19.40</td>
  <td class="cl">Fluoroquinolones activity against Gram-positive cocci: results of multicenter study in Russia</td>
  <td class="cl">L.&nbsp;Stratchounski (Russia)</td>
</tr>
<tr>
  <td class="cc">19.40 - 20.00</td>
  <td class="cl">Management of pneumonia: advantages of monotherapy</td>
  <td class="cl">A.&nbsp;Chuchalin (Russia)</td>
</tr>
<tr>
  <td class="cc">20.00 - 20.20</td>
  <td class="cl">The role of fluoroquinolones in the modern therapy regimens</td>
  <td class="cl">A.&nbsp;Sinopalnikov (Russia)</td>
</tr>
<tr>
  <td class="cc">20.20 - 20.30</td>
  <td colspan="2" class="cl"><i>General discussion</i></td>
</tr>
</table>
</td></tr></table>

<h3>Wednesday, 20 June 2001</h3>

<table border="0" cellpadding="0" cellspacing="5" width="100%"><tr><td bgcolor="#CC9988">
<table border="0" cellpadding="5" cellspacing="1" width="100%">
<tr>
  <td class="cc" nowrap="" width="15%">9.00 - 9.15 <br><img src="../../../rus/images/inv.gif" width="100" height="1" alt="" border="0"></td>
  <td class="cl"><b>Opening ceremony</b></td>
  <td class="cl" width="25%">V.&nbsp;Pokrovsky (Russia), <br>S.&nbsp;Tkachenko (Russia), 
<br>J.&nbsp;Acar (France), <br>S.&nbsp;Lerner (USA)</td>
</tr>
<tr><th colspan="3"><h5>PLENARY SESSION. Main Hall</h5>
<b>Co-chairmen: A.&nbsp;Egorov (Russia), C.E.&nbsp;Nord (Sweden), V.&nbsp;Pokrovsky (Russia)</b></th></tr>
<tr>
  <td class="cc">9.15 - 9.40</td>
  <td class="cl">History of antibioticotherapy in Russia: lessons for the New Millennium</td>
  <td class="cl">Yu.&nbsp;Dudnik (Russia)</td>
</tr>
<tr>
  <td class="cc">&nbsp; 9.40 - 10.05</td>
  <td class="cl">Current state of antimicrobial resistance in Europe</td>
  <td class="cl">H.&nbsp;Goossens (Belgium)</td>
</tr>
<tr>
  <td class="cc">10.05 - 10.25</td>
  <td class="cl">Antimicrobial resistance in Russia</td>
  <td class="cl">L.&nbsp;Stratchounski (Russia)</td>
</tr>
<tr>
  <td class="cc">10.25 - 10.35</td>
  <td class="cl" colspan="2"><i>Coffee break</i></td>
</tr>
<tr>
  <td class="cc">10.35 - 11.00</td>
  <td class="cl">Modern achievements in antibacterial therapy: where are we now?</td>
  <td class="cl">A.&nbsp;Bryskier (France)</td>
</tr>
<tr>
  <td class="cc">11.00 - 11.25</td>
  <td class="cl">Strategy of the virulence of microorganisms</td>
  <td class="cl">S.&nbsp;Sidorenko (Russia)</td>
</tr>
<tr>
  <td class="cc">11.25 - 11.50</td>
  <td class="cl">Clinical significance of the microecology disturbances during antibacterial therapy</td>
  <td class="cl">C.E.&nbsp;Nord (Sweden)</td>
</tr>
<tr>
  <td class="cc">11.50 - 12.15</td>
  <td class="cl" colspan="2"><i>Coffee break</i></td>
</tr>
</table>
</td></tr></table>

<table border="0" cellpadding="0" cellspacing="5" width="100%"><tr><td bgcolor="#CC9988">
<table border="0" cellpadding="5" cellspacing="1" width="100%">
<tr><th colspan="3"><h5>SYMPOSIA SESSION</h5></th></tr>
<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium I. Hall 3 <br>Modern tendencies in the therapy of mycoses</font></h5>
<b>Co-chairmen: S.&nbsp;Burova (Russia), N.&nbsp;Klimko (Russia), M.&nbsp;Richardson (UK)</b>
<br><i>Supported by &quot;Gilead&quot; and &quot;Pfizer&quot;</i></td></tr>
<tr>
  <td class="cc" nowrap="" width="15%">12.15 - 12.45 <br><img src="../../../rus/images/inv.gif" width="100" height="1" alt="" border="0"></td>
  <td class="cl">Modern antifungals for the therapy of invasive mycoses</td>
  <td class="cl" width="25%">M.&nbsp;Richardson (UK)</td>
</tr>
<tr>
  <td class="cc">12.45 - 13.05</td>
  <td class="cl">Candidemia and acute disseminated candidosis in ICU patients</td>
  <td class="cl">N.&nbsp;Klimko (Russia)</td>
</tr>
<tr>
  <td class="cc">13.05 - 13.25</td>
  <td class="cl">Diagnosis and treatment of invasive aspergillosis</td>
  <td class="cl">A.&nbsp;Maschan (Russia)</td>
</tr>
<tr>
  <td class="cc">13.25 - 14.00</td>
  <td class="cl">Current approaches to the management of fungal urinary tract infections</td>
  <td class="cl">K.&nbsp;Naber (Germany)</td>
</tr>
<tr>
  <td class="cc">14.00 - 15.00</td>
  <td class="cl" colspan="2"><i>Lunch</i></td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium II. Main Hall <br>Policy of the selection of antibacterial agents in ICUs</font></h5>
<b>Co-chairmen: B.&nbsp;Gelfand (Russia), L.&nbsp;Stratchounski (Russia), S.&nbsp;Yakovlev (Russia)</b> <br><i>Supported by &quot;Merck, Sharp &amp; Dohme&quot;</i></td></tr>
<tr>
  <td class="cc" nowrap="" width="15%">12.15 - 12.35</td>
  <td class="cl">Pharmacological and microbiological basis for usage of carbapenems</td>
  <td class="cl" width="25%">S.&nbsp;Yakovlev (Russia)</td>
</tr>
<tr>
  <td class="cc">12.35 - 13.05</td>
  <td class="cl">De-escalation therapy of serious infections</td>
  <td class="cl">А.&nbsp;Rodloff (Germany)</td>
</tr>
<tr>
  <td class="cc">13.05 - 13.25</td>
  <td class="cl">Role of carbapenems in the therapy of infections caused by ESBL-producing microorganisms</td>
  <td class="cl">L.&nbsp;Stratchounski (Russia)</td>
</tr>
<tr>
  <td class="cc">13.25 - 13.45</td>
  <td class="cl">Algorithms of the management of patients with surgical sepsis Russia</td>
  <td class="cl">B.&nbsp;Gelfand (Russia)</td>
</tr>
<tr>
  <td class="cc">13.45 - 14.00</td>
  <td class="cl" colspan="2"><i>General discussion</i></td>
</tr>
<tr>
  <td class="cc">14.00 - 15.00</td>
  <td class="cl" colspan="2"><i>Lunch</i></td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium III. Main Hall <br>New possibilities of therapy of serious bacterial infections</font></h5>
<b>Co-chairmen: A.&nbsp;Rodloff (Germany), S.&nbsp;Sidorenko (Russia), L.&nbsp;Stratchounski
(Russia)</b> <br><i>Supported by &quot;Pfizer&quot;</i></td></tr>
<tr>
  <td class="cc">15.00 - 15.30</td>
  <td class="cl"><i>In vitro</i> activity of sulperazone and its implications for clinical practice</td>
  <td class="cl">А.&nbsp;Rodloff (Germany)</td>
</tr>
<tr>
  <td class="cc">15.30 - 16.00</td>
  <td class="cl">Modern tendencies in the empiric therapy of patients with intra-abdominal infections</td>
  <td class="cl">L.&nbsp;Stratchounski (Russia)</td>
</tr>
<tr>
  <td class="cc">16.00 - 16.30</td>
  <td class="cl">Position of <font face="Symbol">b</font>-lactam/<font face="Symbol">b</font>-lactamase inhibitor combinations in lung infections</td>
  <td class="cl">H.&nbsp;Lode (Germany)</td>
</tr>
<tr>
  <td class="cc">16.30 - 17.00</td>
  <td class="cl">Optimization of selection of antibacterial drugs in immunocompromised patients</td>
  <td class="cl">G.&nbsp;Klyasova (Russia)</td>
</tr>
<tr>
  <td class="cc">17.00 - 17.30</td>
  <td class="cl">Clinical experience with <font face="Symbol">b</font>-lactam/<font face="Symbol">b</font>-lactamase inhibitors</td>
  <td class="cl">V.&nbsp;Korten (Turkey)</td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium IV. Hall 3 <br>Surveillance of diphtheria in Europe and Russian Federation</font></h5>
<b>Co-chairmen: A.&nbsp;Efstratiou (UK), P.&nbsp;Grimont (France), N.&nbsp;Maksimova (Russia)</b> <br><i>Within the remit of the European Commission DG RTD INCO Copernicus programme
IC15.CT.98.0302</i></td></tr>
<tr>
  <td class="cc">15.00 - 15.30</td>
  <td class="cl">Current situation with diphtheria in Europe: role of EC programmes in microbiological surveillance of diphtheria</td>
  <td class="cl">A.&nbsp;Efstratiou (UK)</td>
</tr>
<tr>
  <td class="cc">15.30 - 16.00</td>
  <td class="cl">Laboratory diagnosis of diphtheria</td>
  <td class="cl">I.&nbsp;Mazurova (Russia)</td>
</tr>
<tr>
  <td class="cc">16.00 - 16.30</td>
  <td class="cl">Molecular typing of <i>Corynebacterium</i> spp. The <i>C.diphtheriae</i> ribotype project</td>
  <td class="cl">P.&nbsp;Grimont (France)</td>
</tr>
<tr>
  <td class="cc">16.30 - 17.00</td>
  <td class="cl">Control and management of diphtheria: WHO view</td>
  <td class="cl">N.&nbsp;Emiroglu (Denmark)</td>
</tr>
<tr>
  <td class="cc">17.00 - 17.30</td>
  <td class="cl" colspan="2"><i>General discussion</i></td>
</tr>
</table>
</td></tr></table>

<br>
<h3>Thursday, 21 June 2001</h3>

<table border="0" cellpadding="0" cellspacing="5" width="100%"><tr><td bgcolor="#CC9988">
<table border="0" cellpadding="5" cellspacing="1" width="100%">
<tr><th colspan="3"><h5>PLENARY SESSION. Main Hall</h5>
<b>Co-chairmen: H.&nbsp;Giamarellou (Greece), Yu.&nbsp;Lobzin (Russia), A.&nbsp;Firsov (Russia)</b></th></tr>
<tr>
  <td class="cc">9.00 - 9.25 <br><img src="../../../rus/images/inv.gif" width="100" height="1" alt="" border="0"></td>
  <td class="cl">Bioterrorism: role of antimicrobial agents</td>
  <td class="cl">E.&nbsp;Rubinstein (Israel)</td>
</tr>
<tr>
  <td class="cc" nowrap="" width="15%">9.25 - 9.50</td>
  <td class="cl">Clinical significance of antibiotic influence of antibiotics on immunity</td>
  <td class="cl" width="25%">M.-T.&nbsp;Labro (France)</td>
</tr>
<tr>
  <td class="cc">&nbsp; 9.50 - 10.15</td>
  <td class="cl">Problems of antibiotic prophylaxis in surgery</td>
  <td class="cl">L.&nbsp;Zueva (Russia)</td>
</tr>
<tr>
  <td class="cc">10.15 - 10.30</td>
  <td class="cl" colspan="2"><i>Coffee break</i></td>
</tr>
<tr>
  <td class="cc">10.30 - 11.00</td>
  <td class="cl">Antibiotic policy in hospital settings</td>
  <td class="cl">H.&nbsp;Giamarellou (Greece)</td>
</tr>
<tr>
  <td class="cc">11.00 - 11.30</td>
  <td class="cl">Epidemiology of resistance in <i>Streptococcus pneumoniae</i></td>
  <td class="cl">P.&nbsp;Appelbaum (USA)</td>
</tr>
<tr>
  <td class="cc">11.30 - 12.00</td>
  <td class="cl">Reasons for non-efficacy of antibiotics</td>
  <td class="cl">J.&nbsp;Acar (France)</td>
</tr>
<tr>
  <td class="cc">12.00 - 12.05</td>
  <td class="cl" colspan="2"><i>Result of рThe Best posterс competition</i></td>
</tr>
</table>
</td></tr></table>

<table border="0" cellpadding="0" cellspacing="5" width="100%"><tr><td bgcolor="#CC9988">
<table border="0" cellpadding="5" cellspacing="1" width="100%">
<tr><th colspan="3"><h5>SYMPOSIA</h5></th></tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium V. Hall 3 <br>Perspectives of anti-infective therapy in the new millennium</font></h5>
<b>Co-chairmen: Yu.&nbsp;Belousov (Russia), B.&nbsp;Gelfand (Russia), P.&nbsp;Dellinger (USA)</b> <br><i>Supported by &quot;GlaxoSmithKline&quot;</i></td></tr>
<tr>
  <td class="cc">10.00 - 10.20 <br><img src="../../../rus/images/inv.gif" width="100" height="1" alt="" border="0"></td>
  <td class="cl">Principles of development of antibiotic formulary for multi-purpose hospitals based on pharmacoeconomic approach</td>
  <td class="cl">Yu.&nbsp;Belousov (Russia)</td>
</tr>
<tr>
  <td class="cc">10.20 - 10.40</td>
  <td class="cl">Rational antibacterial therapy of nosocomial pneumonia</td>
  <td class="cl">A.&nbsp;Sinopalnikov (Russia)</td>
</tr>
<tr>
  <td class="cc">10.40 - 11.20</td>
  <td class="cl">Antibiotic prophylaxis for scheduled surgical procedures</td>
  <td class="cl">P.&nbsp;Dellinger (USA)</td>
</tr>
<tr>
  <td class="cc">11.20 - 11.40</td>
  <td class="cl">Algorithms of antimicrobial therapy in critical neutropenia</td>
  <td class="cl">G.&nbsp;Klyasova (Russia)</td>
</tr>
<tr>
  <td class="cc">11.40 - 12.00</td>
  <td class="cl">Place of mupirocin in eradication of staphylococcal carriage</td>
  <td class="cl">N.&nbsp;Dmitrieva (Russia)</td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium VI. Main Hall <br>Federal guidelines for physicians as a tool for optimization of antimicrobial therapy</font></h5>
<b>Co-chairmen: Yu.&nbsp;Belousov (Russia), H.&nbsp;Lode (Germany), А.&nbsp;Tzoi (Russia)</b> <br><i>Under auspices of All-Russian Public Foundation &quot;Human Health&quot; and PEG</i></td></tr>
<tr>
  <td class="cc" nowrap="" width="15%">12.15 - 12.40</td>
  <td class="cl">From clinical guidelines and standards to Federal guidelines for phisicians for usage of pharmaceutical agents</td>
  <td class="cl" width="25%">Yu.&nbsp;Belousov (Russia)</td>
</tr>
<tr>
  <td class="cc">12.40 - 13.05</td>
  <td class="cl">Practice of usage of drug formulary in pneumonia</td>
  <td class="cl">H.&nbsp;Lode (Germany)</td>
</tr>
<tr>
  <td class="cc">13.05 - 13.35</td>
  <td class="cl">Peculiarities and stages of development of regional formulary of antimicrobials</td>
  <td class="cl">A.&nbsp;Shalunov (Russia)</td>
</tr>
<tr>
  <td class="cc">13.35 - 14.00</td>
  <td class="cl">Rational choice of antibiotics for the therapy of gram-positive  infections</td>
  <td class="cl">S.&nbsp;Yakovlev (Russia)</td>
</tr>
<tr>
  <td class="cc">14.00 - 15.00</td>
  <td class="cl" colspan="2"><i>Lunch</i></td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium VII. Molecular epidemiology and diagnostics of bacterial infections</font></h5>
<b>Co-chairmen: M.&nbsp;Achtman (Germany), E.&nbsp;Kaczmarski (UK), A.&nbsp;Platonov (Russia)</b></td></tr>
<tr>
  <td class="cc">12.15 - 12.40</td>
  <td class="cl">Molecular epidemiology of bacterial infections</td>
  <td class="cl">M.&nbsp;Achtman (Germany)</td>
</tr>
<tr>
  <td class="cc">12.40 - 13.00</td>
  <td class="cl">Genetic methods for detection of antibacterial resistance</td>
  <td class="cl">M.&nbsp;Edelstein (Russia)</td>
</tr>
<tr>
  <td class="cc">13.00 - 13.30</td>
  <td class="cl">Non-cultural methods of diagnosis of meningococcal infections</td>
  <td class="cl">E.&nbsp;Kaczmarski (UK)</td>
</tr>
<tr>
  <td class="cc">13.30 - 14.00</td>
  <td class="cl">Genodiagnostics and genotyping of pathogens causing bacterial meningitis in Russia</td>
  <td class="cl">A.&nbsp;Platonov (Russia)</td>
</tr>
<tr>
  <td class="cc">14.00 - 14.30</td>
  <td class="cl" colspan="2"><i>Lunch</i></td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium VIII. Main Hall <br>Position of parenteral cephalosporins in the therapy of nosocomial infections</font></h5>
<b>Co-chairmen: J.&nbsp;Acar (France), V.&nbsp;Rudnov (Russia), S.&nbsp;Sidorenko (Russia)</b> <br><i>Supported by &quot;Brisol-Mayers Squibb&quot;</i></td></tr>
<tr>
  <td class="cc" nowrap="" width="15%">15.00 - 15.30</td>
  <td class="cl">New trends in etiology of infections in ICUs</td>
  <td class="cl" width="25%">J.&nbsp;Acar (France)</td>
</tr>
<tr>
  <td class="cc">15.30 - 16.00</td>
  <td class="cl">Usage of cephalosporins for the therapy of pseudomonal infections</td>
  <td class="cl">S.&nbsp;Sidorenko (Russia)</td>
</tr>
<tr>
  <td class="cc">16.00 - 16.30</td>
  <td class="cl">Pharmacoeconomic approaches to the selection of cephalosporins</td>
  <td class="cl">V.&nbsp;Rudnov (Russia)</td>
</tr>
<tr>
  <td class="cc">16.30 - 17.00</td>
  <td class="cl">Current views on the therapy of nosocomial pneumonia</td>
  <td class="cl">R.&nbsp;Kozlov (Russia)</td>
</tr>
<tr>
  <td class="cc">17.00 - 17.30</td>
  <td class="cl" colspan="2"><i>General discussion</i></td>
</tr>

<tr><td class="cc" colspan="3"><h5><font color="#990000">Symposium IX. Hall 3 <br>Perspectives of usage of new fluoroquinolones</font></h5>
<b>Co-chairmen: E.&nbsp;Rubinstein (Israel), L.&nbsp;Stratchounski (Russia), V.&nbsp;Yakovlev (Russia)</b></td></tr>
<tr>
  <td class="cc">15.00 - 15.30</td>
  <td class="cl">Modern problems of antibacterial therapy of respiratory infections</td>
  <td class="cl">E.&nbsp;Rubinstein (Israel)</td>
</tr>
<tr>
  <td class="cc">15.30 - 16.00</td>
  <td class="cl">Antimicrobial resistance in Russia and respiratory fluoroquinolones</td>
  <td class="cl">L.&nbsp;Stratchounski (Russia)</td>
</tr>
<tr>
  <td class="cc">16.00 - 16.30</td>
  <td class="cl">Place of fluoroquinolones in therapy of acute exacerbations of chronic bronchitis</td>
  <td class="cl">А.&nbsp;Synopalnikov (Russia)</td>
</tr>
<tr>
  <td class="cc">16.30 - 17.00</td>
  <td class="cl">Strategy of choice of antibiotics in ambulatory practice. Possibilities of usage of respiratory fluoroquinolones</td>
  <td class="cl">S.&nbsp;Yakovlev (Russia)</td>
</tr>
<tr>
  <td class="cc">17.00 - 17.30</td>
  <td class="cl" colspan="2"><i>General discussion</i></td>
</tr>
</table>
</td></tr></table>

<br>
<!-- begin footer -->
<table border="0" cellpadding="5" cellspacing="0" width="100%">
<tr>
  <td style="text-align: left; vertical-align: bottom;" align="left" valign="bottom"><div class="t8">&copy; 2000-2006 IAC SSMA &middot; E-mail: <a href="mailto:website@antibiotic.ru" title="Send e-mail">website&#64;antibiotic&#46;ru</a></div></td>
  <td colspan="2" valign="top" align="right"><font size="1"><!-- SpyLOG v2 f:0211 --><script language="javascript">
u="u607.38.spylog.com";d=document;nv=navigator;na=nv.appName;p=1;
bv=Math.round(parseFloat(nv.appVersion)*100);
n=(na.substring(0,2)=="Mi")?0:1;rn=Math.random();z="p="+p+"&rn="+rn;y="";
y+="<a href='http://"+u+"/cnt?f=3&p="+p+"&rn="+rn+"' target=_blank>";
y+="<img src='http://"+u+"/cnt?"+z+
"&r="+escape(d.referrer)+"&pg="+escape(window.location.href)+"' border=0  width=88 height=31  alt='SpyLOG'>";
y+="</a>"; d.write(y);if(!n) { d.write("<"+"!--"); }//--></script><noscript>
<a href="../../../index-15.htm?f=3&p=1" target="_blank">
<img src="../../../digits.png?p=1" alt='SpyLOG' border='0' width="88" height="31">
</a></noscript><script language="javascript1.2"><!--
if(!n) { d.write("--"+">"); }//--></script><!-- SpyLOG  --></font></td>
</tr>
</table>
<!-- end of footer -->

<hr size="1">
  

</center>
</body>
</html>
